Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL
Clinical trial NCT07106723 · RECRUITING
Trial details
- NCT number
- NCT07106723
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2029-01-07
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.